Home > News > Archive: 2012

Press Releases

01 October 2012

Generics Announces Positive Results From Phase 2a Nausea & Vomiting Study In Cancer Patients

12 May 2012

Generics Announces Excellent Phase 2 Results For APD421 In PONV

04 January 2012

Phase 2 Study Initiated With APD421 In Post-Operative Nausea & Vomiting (PONV)